Video

What Great CDMO Selection Looks Like In 2026

Source: Outsourced Pharma

This segment of the Outsourced Pharma Live event, “The Unfiltered Truth About CDMO Selection,” examines how experienced sponsors should redefine a “great” CDMO selection in 2026, moving beyond capacity and technical capability to focus on execution under uncertainty, the ability to manage change without contract disruption, right-first-time performance, and long-term business viability. Featuring panelist Christine Sheaffer, Manufacturing & Supply Consultant and fmr. VP of Manufacturing & Supply at Spark Therapeutics.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)